Irinotecan/vincristineLack of efficacy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1921卷 / 1期

关键词：

D O I：

10.1007/s40278-022-22153-9

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：159 / 159

相关论文

共 50 条

[21] Cyclophosphamide/dactinomycin/vincristineLack of efficacy: case report
Reactions Weekly, 2024, 2022 (1) : 98 - 98
[22] Prednisolone/propranolol/vincristineLack of efficacy: case report
Reactions Weekly, 2021, 1860 (1) : 298 - 298
[23] Cyclophosphamide/prednisone/vincristineLack of efficacy: case report
Reactions Weekly, 2022, 1916 (1) : 163 - 163
[24] Cyclophosphamide/dactinomycin/vincristineLack of efficacy: case report
Reactions Weekly, 2021, 1873 (1) : 88 - 88
[25] Dactinomycin/ifosfamide/vincristineLack of efficacy: case report
Reactions Weekly, 2022, 1896 (1) : 166 - 166
[26] Cyclophosphamide/prednisone/vincristineLack of efficacy: case report
Reactions Weekly, 2021, 1863 (1) : 113 - 113
[27] Cytarabine/prednisolone/vincristineLack of efficacy: case report
Reactions Weekly, 2022, 1922 (1) : 206 - 206
[28] Cisplatin/cyclophosphamide/vincristineLack of efficacy: case report
Reactions Weekly, 2024, 2030 (1) : 134 - 134
[29] Cyclophosphamide/doxorubicin/vincristineLack of efficacy: case report
Reactions Weekly, 2023, 1948 (1) : 149 - 149
[30] Carboplatin/Etoposide/VincristineLack of efficacy: case report
Reactions Weekly, 2025, 2047 (1) : 104 - 104

← 1 2 3 4 5 →